US PATENT SUBCLASS 424 / 9.351
.~.~.~ The region of the imaging agent responsibile for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

9.1  DF  IN VIVO DIAGNOSIS OR IN VIVO TESTING {7}
9.3  DF  .~ Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) {7}
9.35  DF  .~.~ Carbohydrate or derivative thereof attached to or complexed with the agent {1}
9.351.~.~.~ The region of the imaging agent responsibile for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids

DEFINITION

Classification: 424/9.351

The region of the imaging agent responsible for binding to an in vivo target or the region of the target responsible for binding to the agent is specifically recited functionally or as a sequence of amino acids, carbohydrate residues, or nucleic acids:

(under subclass 9.35) Subject matter wherein the carbohydrate attached to said imaging agent directs delivery of said imaging agent to a specific in vivo target and wherein the specific binding properties of either the in vivo target or the carbohydrate are described by a saccharide sequence or wherein the particular region of binding is described functionally (e.g., a unique region of an imaging agent defined by the fact that it binds a specific region of a target cell, but does not cross react with another region on the target cell, etc.)